ChemPartner Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2,000

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 6

  • Investments
  • 5

ChemPartner General Information

Description

Provider of a drug discovery and development service intended to offer high-quality and cost-effective services to the biopharmaceutical industry. The company offers a broad range of integrated services across the drug discovery and development process, enabling it to serve the pharmaceutical and biotechnology companies around the globe.

Contact Information

Formerly Known As
ShangPharma
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • Room 301
  • No. 965, Halley Road
  • Shanghai, 201203
  • China
+86
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • Room 301
  • No. 965, Halley Road
  • Shanghai, 201203
  • China
+86

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ChemPartner Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ChemPartner‘s full profile, request access.

Request a free trial

ChemPartner Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of a drug discovery and development service intended to offer high-quality and cost-effective services to the b
Drug Discovery
Shanghai, China
2,000 As of 2026

Beijing, China
 

Toronto, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ChemPartner Competitors (57)

One of ChemPartner’s 57 competitors is Pharmaron, a Formerly VC-backed company based in Beijing, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pharmaron Formerly VC-backed Beijing, China
Dalton Pharma Services Corporate Backed or Acquired Toronto, Canada
Latitude Pharmaceuticals Private Debt Financed San Diego, CA
Aragen Life Sciences Private Equity-Backed Hyderabad, India
WuXi Chemistry Corporation Shanghai, China
You’re viewing 5 of 57 competitors. Get the full list »

ChemPartner Patents

ChemPartner Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026194946-A1 Camptothecin compound and use thereof Pending 18-Mar-2025
WO-2026158702-A1 Anti-tumor drug, pharmaceutical composition, and use thereof Pending 27-Jan-2025
WO-2026098695-A1 Antibody labeling method Pending 08-Nov-2024
AU-2020401188-A1 Alpha-5 beta-1 inhibitors Active 10-Dec-2019
AU-2020401188-B2 Alpha-5 beta-1 inhibitors Active 10-Dec-2019 C07C279/18
To view ChemPartner’s complete patent history, request access »

ChemPartner Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ChemPartner Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ChemPartner‘s full profile, request access.

Request a free trial

ChemPartner Investments (5)

ChemPartner’s most recent deal was a Later Stage VC with Circle Pharma for . The deal was made on 02-Dec-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Circle Pharma 02-Dec-2018 Later Stage VC Drug Discovery
Circle Pharma 25-Apr-2017 Later Stage VC Drug Discovery
Boteng Zhituo Pharmaceutical 08-Sep-2016 Corporate Pharmaceuticals
Morphic Therapeutic 30-Jun-2016 Early Stage VC Drug Discovery
Morphic Therapeutic 01-Jun-2015 Seed Round Drug Discovery
To view ChemPartner’s complete investments history, request access »

ChemPartner Exits (3)

ChemPartner’s most recent exit was on 08-Sep-2016 from Boteng Zhituo Pharmaceutical. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Boteng Zhituo Pharmaceutical 08-Sep-2016 Completed
Morphic Therapeutic 30-Jun-2016 Completed
  • 11 buyers
Morphic Therapeutic 01-Jun-2015 Seed Round Completed
  • 4 buyers
To view ChemPartner’s complete exits history, request access »

ChemPartner FAQs

  • When was ChemPartner founded?

    ChemPartner was founded in 2003.

  • Where is ChemPartner headquartered?

    ChemPartner is headquartered in Shanghai, China.

  • What is the size of ChemPartner?

    ChemPartner has 2,000 total employees.

  • What industry is ChemPartner in?

    ChemPartner’s primary industry is Drug Discovery.

  • Is ChemPartner a private or public company?

    ChemPartner is a Private company.

  • What is the current valuation of ChemPartner?

    The current valuation of ChemPartner is .

  • What is ChemPartner’s current revenue?

    The current revenue for ChemPartner is .

  • How much funding has ChemPartner raised over time?

    ChemPartner has raised $117M.

  • Who are ChemPartner’s investors?

    MAGS Capital and TPG have invested in ChemPartner.

  • Who are ChemPartner’s competitors?

    Pharmaron, Dalton Pharma Services, Latitude Pharmaceuticals, Aragen Life Sciences, and WuXi Chemistry are some of the 57 competitors of ChemPartner.

  • When was ChemPartner acquired?

    ChemPartner was acquired on 16-Aug-2018.

  • Who acquired ChemPartner?

    ChemPartner was acquired by Chempartner Pharmatech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process